The deal grants Torrent Pharma access to a thriving pharmaceutical business. JB Pharma makes drugs for gastroenterology, ...

Torrent said on Sunday that it would acquire a controlling stake in JB Pharma from global investment firm KKR, at an equity ...

Prabhudas Lilladher recommended accumulate rating on Torrent Pharmaceuticals with a target price of Rs 3850 in its research ...

According to Nuvama Institutional Equities, TRP will initially acquire a 46.39 per cent stake in JBCP from private equity ...

Notwithstanding the medium-term gains, the acquisition of JB Chemicals & Pharmaceuticals brings uncertainty over successful ...

India's Torrent Pharmaceuticals said on Sunday it will acquire a 46.39% controlling stake in smaller peer JB Chemicals and Pharmaceuticals from New York-based investment firm KKR , and plans to merge ...

ICICI Securities recommended hold rating on Torrent Pharma with a target price of Rs 3500 in its research report dated July ...

In a mega deal in the Indian pharmaceutical sector, Torrent Pharmaceuticals has announced plans to acquire a 49.18% ...

Torrent has signed definitive agreements to acquire stake in JB Pharma at an equity valuation of Rs256.89bn ($3bn) on a fully ...

Torrent Pharmaceuticals has announced the acquisition of a controlling stake in JB Pharma from global investment firm KKR at ...

Torrent Pharma makes a bold ₹18,000 crore move to acquire JB Chemicals, signalling a strategic comeback and consolidation ...

Torrent Pharmaceuticals to acquire 46.39% stake in JB Chemicals and Pharmaceuticals, merging to strengthen global presence.